Seth Rosenzweig, MD
Orthopaedic Surgery · New Iberia, LANPI 1679630628
Payments from drug & device makers
Across 105 payments — averaging $66.63 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Stryker$4K
- Arthrex$917
- Zimmer Biomet$804
- ALON Medical Technology$721
- Bioventus LLC$172
- Next Science LLC$140
- plus $418 from 12 others
What the payments were for
- Travel & lodging$3,91356%
- Food & beverage$3,06744%
- Entertainment$160%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Stryker | 50 | $3,824 |
| Arthrex | 11 | $917 |
| Zimmer Biomet | 9 | $804 |
| ALON Medical Technology | 4 | $721 |
| Bioventus LLC | 9 | $172 |
| Next Science LLC | 1 | $140 |
| Pacira Pharmaceuticals Incorporated | 4 | $88 |
| Smith+Nephew | 2 | $63 |
| Ferring Pharmaceuticals Inc. | 3 | $49 |
| KCI USA, Inc. | 2 | $42 |
| Vericel Corporation | 2 | $34 |
| Kowa Pharmaceuticals America, Inc. | 2 | $31 |
| Forte Bio-pharma LLC | 1 | $29 |
| Johnson & Johnson | 1 | $20 |
| Flower Orthopedics Coporation | 1 | $19 |
| Boston Scientific | 1 | $16 |
| Convatec Inc. | 1 | $15 |
| AbbVie | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- MAKO$2,413
- ROSA$703
- Xperience$140
- BlastX$140
- BLUEPRINT PATIENT SPECIFIC INSTRUMENTATION$109
How this compares
$6,996 in reported general payments places this provider in the 60th percentile of 286 orthopaedic surgery providers in Louisiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Daptomycin | 32 | $13,057 |
| Celecoxib | 140 | $3,970 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 245 | $2,284 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 278 | $1,617 |
| Ketorolac Tromethamine | 24 | $442 |
| Cyclobenzaprine Hcl | 67 | $407 |
| Pregabalin | 22 | $250 |
| Doxycycline Hyclate | 27 | $165 |
| Tramadol Hcl | 58 | $154 |
| Methylprednisolone | 20 | $140 |
| Sodium Chloride0.9 % Sodium Chloride | 34 | $121 |
| Ondansetron OdtOndansetron | 14 | $103 |
| Clindamycin Hcl | 14 | $63 |
| Amoxicillin | 13 | $15 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic surgery in New Iberia
- Pierce NunleyShreveport$3.8M
- Christopher HarrodBaton Rouge$3.1M
- Vinod DasaKenner$1.9M
- Jorge IsazaBaton Rouge$1.2M
- Robert ZuraNew Orleans$792K
- Kevin McCarthyBaton Rouge$714K
- Fernando SanchezNew Orleans$655K
- Neil MakiThibodaux$620K
- Timmothy RandellAlexandria$498K
- Robert EastonBaton Rouge$394K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.